Home|Journals|Articles by Year|Audio Abstracts
 

Original Research



Bioelectric impedance phase angle in carcinoma prostate - a hospital-based study

Ruchi Tyagi, Shashank Mishra, Naveen Gaur, Archana Panwar, Dhanesh Saini, Kiran Singh, Deepak Kumar, Ghulam Jeelani.




Abstract

Background: Prostate cancer is the leading cause of cancer death in men worldwide. A common problem faced by both clinicians and patients is that prostate malignancy does not cause symptoms until it metastasizes or become locally advanced. Prostate specific antigen (PSA) one of the important screening tools is controversial as its low predictive value results in high number of unnecessary prostate biopsies.

Objective: To explore bioelectric impedance analysis (BIA) derived phase angle as a screening and prognostic tool in histologically proven prostate cancer.

Material and Methods: This prospective case control study included the measuring of phase angles, PSA, and Gleason scoring in patients of prostate cancer and comparing it with their matched controls using unpaired t-test. All the patients of carcinoma prostate were grouped into various stages and one-way ANOVA was applied followed by post hoc Tukey Krammer test.

Result: Controls showed a mean ± SEM value of 4.790 (0.0424) and cases had a mean ±SEM 3.0048 (0.069). The p-value was

Key words: Bioelectric impedance analysis, prostate cancer, phase angle






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.